nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—FDPS—uterine cervix—cervical cancer	0.0578	0.0924	CbGeAlD
Risedronate—FDPS—decidua—cervical cancer	0.0551	0.0881	CbGeAlD
Risedronate—FDPS—renal system—cervical cancer	0.0541	0.0865	CbGeAlD
Risedronate—FDPS—endometrium—cervical cancer	0.0523	0.0836	CbGeAlD
Risedronate—FDPS—mammalian vulva—cervical cancer	0.0506	0.0809	CbGeAlD
Risedronate—FDPS—uterus—cervical cancer	0.0482	0.077	CbGeAlD
Risedronate—FDPS—female reproductive system—cervical cancer	0.0433	0.0693	CbGeAlD
Risedronate—FDPS—female gonad—cervical cancer	0.0394	0.063	CbGeAlD
Risedronate—FDPS—vagina—cervical cancer	0.0392	0.0626	CbGeAlD
Risedronate—Neuralgia—Topotecan—cervical cancer	0.0258	0.0687	CcSEcCtD
Risedronate—FDPS—lymph node—cervical cancer	0.0253	0.0405	CbGeAlD
Risedronate—PTGS2—epithelium—cervical cancer	0.0223	0.0357	CbGeAlD
Risedronate—PTGS2—uterine cervix—cervical cancer	0.0222	0.0354	CbGeAlD
Risedronate—PTGS2—renal system—cervical cancer	0.0207	0.0331	CbGeAlD
Risedronate—PTGS2—endometrium—cervical cancer	0.02	0.032	CbGeAlD
Risedronate—Bone pain—Topotecan—cervical cancer	0.0187	0.0499	CcSEcCtD
Risedronate—PTGS2—uterus—cervical cancer	0.0185	0.0295	CbGeAlD
Risedronate—Colitis—Topotecan—cervical cancer	0.0172	0.0459	CcSEcCtD
Risedronate—PTGS2—female reproductive system—cervical cancer	0.0166	0.0265	CbGeAlD
Risedronate—Neoplasm—Topotecan—cervical cancer	0.0162	0.0432	CcSEcCtD
Risedronate—PTGS2—female gonad—cervical cancer	0.0151	0.0242	CbGeAlD
Risedronate—PTGS2—vagina—cervical cancer	0.015	0.024	CbGeAlD
Risedronate—Pneumonia—Topotecan—cervical cancer	0.0101	0.0269	CcSEcCtD
Risedronate—Infestation NOS—Topotecan—cervical cancer	0.01	0.0267	CcSEcCtD
Risedronate—Infestation—Topotecan—cervical cancer	0.01	0.0267	CcSEcCtD
Risedronate—PTGS2—lymph node—cervical cancer	0.00971	0.0155	CbGeAlD
Risedronate—Hepatobiliary disease—Topotecan—cervical cancer	0.00947	0.0253	CcSEcCtD
Risedronate—Haemoglobin—Topotecan—cervical cancer	0.00903	0.0241	CcSEcCtD
Risedronate—Rhinitis—Topotecan—cervical cancer	0.00901	0.024	CcSEcCtD
Risedronate—Haemorrhage—Topotecan—cervical cancer	0.00899	0.024	CcSEcCtD
Risedronate—Pharyngitis—Topotecan—cervical cancer	0.00892	0.0238	CcSEcCtD
Risedronate—Angiopathy—Topotecan—cervical cancer	0.00815	0.0218	CcSEcCtD
Risedronate—Immune system disorder—Topotecan—cervical cancer	0.00812	0.0217	CcSEcCtD
Risedronate—Mediastinal disorder—Topotecan—cervical cancer	0.0081	0.0216	CcSEcCtD
Risedronate—Malnutrition—Topotecan—cervical cancer	0.00782	0.0209	CcSEcCtD
Risedronate—Back pain—Topotecan—cervical cancer	0.00757	0.0202	CcSEcCtD
Risedronate—Muscle spasms—Topotecan—cervical cancer	0.00752	0.0201	CcSEcCtD
Risedronate—Anaemia—Topotecan—cervical cancer	0.00723	0.0193	CcSEcCtD
Risedronate—Angioedema—Topotecan—cervical cancer	0.00715	0.0191	CcSEcCtD
Risedronate—Cough—Topotecan—cervical cancer	0.00683	0.0182	CcSEcCtD
Risedronate—Myalgia—Topotecan—cervical cancer	0.00666	0.0178	CcSEcCtD
Risedronate—Chest pain—Topotecan—cervical cancer	0.00666	0.0178	CcSEcCtD
Risedronate—Arthralgia—Topotecan—cervical cancer	0.00666	0.0178	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00661	0.0177	CcSEcCtD
Risedronate—Infection—Topotecan—cervical cancer	0.00634	0.0169	CcSEcCtD
Risedronate—Nervous system disorder—Topotecan—cervical cancer	0.00626	0.0167	CcSEcCtD
Risedronate—Skin disorder—Topotecan—cervical cancer	0.0062	0.0166	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00582	0.0155	CcSEcCtD
Risedronate—Paraesthesia—Topotecan—cervical cancer	0.00573	0.0153	CcSEcCtD
Risedronate—Dyspnoea—Topotecan—cervical cancer	0.00569	0.0152	CcSEcCtD
Risedronate—Dyspepsia—Topotecan—cervical cancer	0.00562	0.015	CcSEcCtD
Risedronate—Gastrointestinal disorder—Topotecan—cervical cancer	0.00551	0.0147	CcSEcCtD
Risedronate—Fatigue—Topotecan—cervical cancer	0.0055	0.0147	CcSEcCtD
Risedronate—Pain—Topotecan—cervical cancer	0.00546	0.0146	CcSEcCtD
Risedronate—Constipation—Topotecan—cervical cancer	0.00546	0.0146	CcSEcCtD
Risedronate—Gastrointestinal pain—Topotecan—cervical cancer	0.00522	0.0139	CcSEcCtD
Risedronate—Urticaria—Topotecan—cervical cancer	0.00507	0.0135	CcSEcCtD
Risedronate—Abdominal pain—Topotecan—cervical cancer	0.00505	0.0135	CcSEcCtD
Risedronate—Body temperature increased—Topotecan—cervical cancer	0.00505	0.0135	CcSEcCtD
Risedronate—Hypersensitivity—Topotecan—cervical cancer	0.0047	0.0126	CcSEcCtD
Risedronate—Asthenia—Topotecan—cervical cancer	0.00458	0.0122	CcSEcCtD
Risedronate—Pruritus—Topotecan—cervical cancer	0.00452	0.0121	CcSEcCtD
Risedronate—Diarrhoea—Topotecan—cervical cancer	0.00437	0.0117	CcSEcCtD
Risedronate—Dizziness—Topotecan—cervical cancer	0.00422	0.0113	CcSEcCtD
Risedronate—Vomiting—Topotecan—cervical cancer	0.00406	0.0108	CcSEcCtD
Risedronate—Rash—Topotecan—cervical cancer	0.00403	0.0107	CcSEcCtD
Risedronate—Dermatitis—Topotecan—cervical cancer	0.00402	0.0107	CcSEcCtD
Risedronate—Headache—Topotecan—cervical cancer	0.004	0.0107	CcSEcCtD
Risedronate—Nausea—Topotecan—cervical cancer	0.00379	0.0101	CcSEcCtD
